Quick Answer
Bio Green Med Solution, Inc. reported Cash And Cash Equivalents At Carrying Value of $3.51 million for the year ending 2025.
- Bio Green Med Solution, Inc. showed an increase of +11.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Bio Green Med Solution, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: $19.54 million | Q3 2010: $18.48 million | Q1 2011: $25.35 million | Q2 2011: $20.61 million | Q3 2011: $27.68 million | Q1 2012: $23.64 million | Q2 2012: $19.96 million | Q3 2012: $17.84 million | Q1 2013: $14.14 million | Q2 2013: $33.67 million | Q3 2013: $34.49 million | Q1 2014: $28.15 million | Q2 2014: $33.46 million | Q3 2014: $26.71 million | Q1 2015: $29.36 million | Q2 2015: $26.90 million | Q3 2015: $22.73 million | Q1 2016: $17.12 million | Q2 2016: $15.93 million | Q3 2016: $18.03 million | Q1 2017: $12.73 million | Q2 2017: $13.59 million | Q3 2017: $26.03 million | Q4 2017: $23.91 million | Q1 2018: $21.73 million | Q2 2018: $19.82 million | Q3 2018: $18.97 million | Q1 2019: $17.93 million | Q2 2019: $15.16 million | Q3 2019: $12.97 million | Q1 2020: $8.92 million | Q2 2020: $25.34 million | Q3 2020: $23.13 million | Q1 2021: $47.78 million | Q2 2021: $43.64 million | Q3 2021: $40.22 million | Q1 2022: $29.64 million | Q2 2022: $29.08 million | Q3 2022: $23.71 million | Q1 2023: $11.44 million | Q2 2023: $10.16 million | Q3 2023: $5.94 million | Q1 2024: $2.80 million | Q2 2024: $6.00 million | Q3 2024: $2.98 million | Q1 2025: $3.45 million | Q2 2025: $4.28 million | Q3 2025: $3.84 million.
- Over the full 18 years of available data (2008 to 2025), Bio Green Med Solution, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 85.5%.
- Historical annual values: Fiscal year 2025: $3.51 million | Fiscal year 2024: $3.14 million | Fiscal year 2023: $3.38 million | Fiscal year 2022: $18.35 million | Fiscal year 2021: $36.56 million | Fiscal year 2020: $33.41 million | Fiscal year 2019: $11.89 million | Fiscal year 2018: $17.50 million | Fiscal year 2017: $23.91 million | Fiscal year 2016: $16.52 million | Fiscal year 2015: $20.44 million | Fiscal year 2014: $24.19 million | Fiscal year 2013: $31.15 million | Fiscal year 2012: $16.41 million | Fiscal year 2011: $24.45 million | Fiscal year 2010: $29.50 million | Fiscal year 2009: $11.49 million | Fiscal year 2008: $24.22 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: